10/4001/01 - Reviews of current treatment for BRONCHO and Asthma in adults and children
Research type: Evidence Synthesis
Start date: October 2010
Publication date: October 2014
Cost: £269,511.00
Contractor: St George's, University of London
Publications
- Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma (in the Cochrane Library via Wiley Online)
- Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children (in the Cochrane Library via Wiley Online)
- Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children (in the Cochrane Library via Wiley Online)
- Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children (in the Cochrane Library via Wiley Online)
- Home-based educational interventions for children with asthma (in the Cochrane Library via Wiley Online)
- Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease (in the Cochrane Library via Wiley Online)
- Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department (MGA-AST) (in the Cochrane Library via Wiley Online)
- Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease (in the Cochrane Library via Wiley Online)
- Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis (in the Cochrane Library via Wiley Online)
- Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews (in the Cochrane Library via Wiley Online)
- Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews (in the Cochrane Library via Wiley Online)
- The effect of adding inhaled corticosteroids to tiotropium and long-acting beta2-agonists for chronic obstructive pulmonary disease (in the Cochrane Library via Wiley Online)
- Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease (in the Cochrane Library via Wiley Online)
- Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease (in the Cochrane Library via Wiley Online)
- Tiotropium versus placebo for chronic obstructive pulmonary disease (in the Cochrane Library via Wiley Online)